Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $0.75 | Change: +$0.10 | %Change: +15.38%
Volume: 91,812 | Day High/Low: 0.75/0.63 | 52 Week High/Low: 0.89/0.435

Snapshot

Last Traded: October 01, 2014 11:47 Transaction Volume: 91,812
Open: $0.75 Previous Close: $0.65
Bid: $0.72 Ask: $0.75
Bid Size: 2,000 Ask Size: 4,500
Market Cap: $64.0m Shares Out: 85.3m
PE Ratio: 2.2 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Blogger says 2014 may be a good year for Canadian Zinc (T.CZN)

Stockhouse Editorial   December 24, 2013
0 stars

Stockhouse Research: Sometimes no news is good news

Another day, another bullboard war. But not much else.

Chris Parry   September 10, 2013
0 stars

Stockhouse Research: The day Niko Resources came to play

Another day, another surprising block of Stockhouse user data.

Chris Parry   September 6, 2013
0 stars

Stockhouse Research: Resverlogix (T.RVX) and Colabor (T.GCL) sparking interest

Newcomers make the list on Stockhouse Research's roundup of what's hot on Stockhouse.com today.

Chris Parry   September 3, 2013
0 stars

Latest Bullboard Posts

  • MEMORY IMPROVEMENT IN AD ETC.

    0 stars

    Memory Loss Associated with Alzheimer's Reversed for First Time Wed, 10/01/2014 - 3:24pm Get today's life science...

    3 stars


  • …this post received 450 reads and thus I believe this is...

    4 stars

    …this post received 450 reads and thus I believe this is what is first and foremost on the minds of the retail investors out there… I...

    3 stars


  • Great rebound.....

    5 stars

    I jumped a bit early in adding just below .70....but not gonna sweat it, when you're bullish on a stock's longer term prospect, well I...

    2 stars


  • RE:Monday's webcast...

    0 stars

    KELSEE AND SANFRAN, NOT THE GRUMBLING BUT THE RETURN OF SWEET SARAH IS THE REASON FOR THE NICE POP!  :) THANKS SARAH. KEEP THEM COMMING...

    3 stars


  • Monday's webcast...

    5 stars

    ...well, well, well SanFran, I just can't help but wonder if all our mumbling and grumbling finally got thru to DM...?... lol...

    3 stars